Preparatory Preparations for the Study of Drug Therapies for Emergency Diseases

Volume 1 - Issue 5

Chang Rok Jeong*

Received: June 10, 2018;   Published: June 18, 2018

DOI: 10.32474/DDIPIJ.2018.01.000121

Full Text PDF

To view the Full Article   Peer-reviewed Article PDF

Abstract

In the US, more than 400,000 medical treatments are carried out each year to eliminate intestinal adhesion. The economic loss from these medical treatments is estimated to be about $1.2 billion. This economic loss has been significant, and the search results from pub med under keyword Intestinal Obstruction have been decreasing since 2015. It is difficult to research and prevent a disease caused by small intestine, which is one of the emergency diseases. Because emergency diseases have structural problems that are very difficult to collect and analyze data for research. Emergency care measures, especially drug development, require a platform that allows public funding and sharing of clinical data. Emergency diseases have scattered clinical data. The research into this emergency disease requires a method of receiving clinical data as a condition to provide free medical treatment to patients through the IRB. There is an urgent need to find the reverse data. Modern society is a time of the Fourth Industrial Revolution. Above all, AI, Deep Learning, and platforms are important keywords. In these times, open and international cooperation is necessary for the safety of emergency patients such as intestinal obstruction. Development guidelines describe how medicine will overcome these shortcomings during the Fourth Industrial Revolution.

Keywords: An emergency disease; Intestinal Obstruction; Deep Learning; Platforms; International Cooperation; Development guidelines for drug development; Ethical guidelines

Abstract| Introduction| The Present State of Study on Emergency Diseases: Focus on Intestinal Obstruction| Why Is It Difficult to Study Emergency Diseases?| The Need for International Funds and Platforms for the Treatment of Emergency Diseases and Drug Development| Conclusion: Proposal of International Cooperation Guidelines for the Study of Emergency Disease| Refernces|